Quick Answer
Anixa Biosciences Inc reported Stockholders Equity of $15.16 million for the year ending 2025.
- Anixa Biosciences Inc showed a decrease of -24.2% in Stockholders Equity from 2024 to 2025.
- This data is from Anixa Biosciences Inc's annual report (Form 10-K), filed with the SEC on January 12, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $738.0 thousand | Q2 2012: -$339.0 thousand | Q3 2012: -$893.1 thousand | Q1 2014: -$5.67 million | Q2 2014: -$4.85 million | Q3 2014: $149.7 thousand | Q1 2015: $8.26 million | Q2 2015: $6.99 million | Q3 2015: $6.00 million | Q1 2016: $3.59 million | Q2 2016: $2.56 million | Q3 2016: $1.72 million | Q1 2017: -$3.82 million | Q2 2017: $3.59 million | Q3 2017: $5.49 million | Q1 2018: $6.44 million | Q2 2018: $6.07 million | Q3 2018: $6.33 million | Q1 2019: $5.48 million | Q2 2019: $6.54 million | Q3 2019: $5.80 million | Q1 2020: $5.44 million | Q2 2020: $5.29 million | Q3 2020: $8.62 million | Q1 2021: $13.60 million | Q2 2021: $37.61 million | Q3 2021: $36.47 million | Q1 2022: $33.96 million | Q2 2022: $32.17 million | Q3 2022: $31.70 million | Q1 2023: $27.79 million | Q2 2023: $26.81 million | Q3 2023: $25.52 million | Q1 2024: $24.61 million | Q2 2024: $23.62 million | Q3 2024: $21.77 million | Q1 2025: $17.85 million | Q2 2025: $16.07 million | Q3 2025: $16.60 million | Q4 2025: $15.16 million | Q1 2026: $15.08 million.
- Over the full 17 years of available data (2009 to 2025), Anixa Biosciences Inc's Stockholders Equity has grown by 240.5%.
- Historical annual values: Fiscal year 2025: $15.16 million | Fiscal year 2024: $20.00 million | Fiscal year 2023: $24.34 million | Fiscal year 2022: $29.05 million | Fiscal year 2021: $35.44 million | Fiscal year 2020: $8.76 million | Fiscal year 2019: $5.24 million | Fiscal year 2018: $5.43 million | Fiscal year 2017: $7.92 million | Fiscal year 2016: $987.5 thousand | Fiscal year 2015: $5.05 million | Fiscal year 2014: $4.01 million | Fiscal year 2013: -$3.32 million | Fiscal year 2012: -$1.19 million | Fiscal year 2011: $1.06 million | Fiscal year 2010: $4.60 million | Fiscal year 2009: $4.45 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: